Torray Investment Partners LLC Has $2.03 Million Position in The Cooper Companies, Inc. $COO

Torray Investment Partners LLC boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 52.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 24,822 shares of the medical device company’s stock after buying an additional 8,506 shares during the quarter. Torray Investment Partners LLC’s holdings in Cooper Companies were worth $2,034,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Bell Investment Advisors Inc raised its position in shares of Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares in the last quarter. True Wealth Design LLC raised its position in shares of Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after acquiring an additional 383 shares in the last quarter. Cromwell Holdings LLC raised its position in shares of Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after acquiring an additional 273 shares in the last quarter. Board of the Pension Protection Fund bought a new position in shares of Cooper Companies in the 4th quarter worth about $41,000. Finally, CYBER HORNET ETFs LLC bought a new position in shares of Cooper Companies in the 2nd quarter worth about $36,000. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on COO shares. Needham & Company LLC lifted their price objective on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Wednesday, March 4th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $73.00 target price on shares of Cooper Companies in a research report on Friday, January 9th. Finally, Citigroup decreased their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded down $0.77 during midday trading on Thursday, reaching $66.15. The company’s stock had a trading volume of 147,242 shares, compared to its average volume of 2,023,646. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $89.83. The firm has a 50 day moving average price of $74.84 and a 200-day moving average price of $76.50. The stock has a market capitalization of $12.91 billion, a P/E ratio of 32.75, a PEG ratio of 1.74 and a beta of 1.07. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the business earned $0.92 EPS. The company’s revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 4.62 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.